|
TYRA Tyra Biosciences Inc 1863127 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-39,305,000.00 |
| Balance Sheet |
|
Current Assets
|
$394,613,000.00 |
|
Assets
|
$412,040,000.00 |
|
Current Liabilities
|
$19,256,000.00 |
|
Liabilities
|
$24,465,000.00 |
|
Equity
|
$387,575,000.00 |
|
Shares Out
|
59469687.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-32,571,000.00 |
|
Investing Cash Flow
|
$-120,244,000.00 |
| Market Analysis |
Market Cap
|
$1,966,067,852.22 |
|
Price
|
$31.12 |
|
BVPS
|
6.52 |
|
PB
|
5.07 |
|
EPS
|
-0.64 |
|
FCF
|
$-32,659,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Apr |
May |
Jun |
| 2026-03-02 |
-0.57 |
|
|
2026-05-13 |
-0.64 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.47 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.50 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TYRA documents filed with the SEC.
TYRA Filings
Clear
